- An assessment by the Statin Cognitive Safety Task Force🔍
- NLA Task Force on Statin Safety🔍
- An assessment by the Statin cognitive safety task force🔍
- 2014 Statin Safety Task Force🔍
- An assessment by the Statin Muscle Safety Task Force🔍
- Statin Safety and Associated Adverse Events🔍
- Statin Use for the Primary Prevention of Cardiovascular Disease in ...🔍
- An Assessment of Statin Safety🔍
An assessment by the Statin Cognitive Safety Task Force
An assessment by the Statin Cognitive Safety Task Force: 2014 update
The National Lipid Association's Safety Task Force convened a consensus conference of experts to develop a position statement on cognitive function to ...
An assessment by the Statin Cognitive Safety Task Force: 2014 update
The 2006 Statin Safety Task Force report addressed the question, ''Do statins impair memory or cognition in some patients?'' That Task Force ...
NLA Task Force on Statin Safety - 2014 update
An assessment by the Statin Cognitive Safety Task Force: 2014 update. Carlos H. Rojas-Fernandez, BSc(Pharm), PharmD*, Larry B. Goldstein, MD,. Allan I. Levey ...
An assessment by the Statin cognitive safety task force: 2014 update ...
The National Lipid Association's Safety Task Force convened a consensus conference of experts to develop a position statement on cognitive function to ...
2014 Statin Safety Task Force - NATAP
needed, including development of a validated index of statin muscle intolerance. 5. Page 6. www.lipid.org. An Assessment by the Statin Cognitive. Safety Task ...
An assessment by the Statin Cognitive Safety Task Force: 2014 ...
Semantic Scholar extracted view of "An assessment by the Statin Cognitive Safety Task Force: 2014 update." by C. Rojas-Fernandez et al.
An assessment by the Statin Muscle Safety Task Force: 2014 update
The National Lipid Association's Muscle Safety Expert Panel was charged with the duty of examining the definitions for statin-associated muscle adverse ...
An assessment by the Statin Cognitive Safety Task Force: 2014 ...
The National Lipid Association's Safety Task Force convened a consensus conference of experts to develop a position statement on cognitive function to ...
Statin Safety and Associated Adverse Events: A Scientific Statement ...
... Safety Task Force. An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(suppl):S5–S16. doi: 10.1016 ...
Statin Use for the Primary Prevention of Cardiovascular Disease in ...
41. US Preventive Services Task Force. Risk assessment for cardiovascular disease with nontraditional risk factors: US Preventive Services ...
An assessment by the Statin Cognitive Safety Task Force: 2014 update
An assessment by the Statin Cognitive Safety Task Force: 2014 update. Carlos H. Rojas-Fernandez, BSc(Pharm), PharmD*, Larry B. Goldstein, MD,. Allan I. Levey ...
(PROSPER), there was no decline in cognitive ... Final conclusions and recommendations of the. National Lipid Association Statin Safety Assessment Task. Force.
Important safety label changes to cholesterol-lowering statin drugs
Cohen DE, Anania FA, Chalasani N; for the National Lipid Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety ...
Evaluation of Time to Benefit of Statins for the Primary Prevention of ...
... Safety Task Force. An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol. 2014;8(3)(suppl):S5-S16. doi ...
Statins and their effect on cognition: Let's clear up the confusion
Rojas-Fernandez CH, Goldstein LB, Levey AI, et al. An assessment by the Statin Cognitive Safety Task Force: 2014 update. J Clin Lipidol 2014;8: ...
Interpretation of the evidence for the efficacy and safety of statin ...
The co-primary outcomes were Alzheimer's Disease Assessment Scale-cognitive ... An assessment by the Statin Muscle Safety Task Force: 2014 update. J Clin ...
An assessment by the Statin Muscle Safety Task Force: 2014 update
Abstract The National Lipid Association's Muscle Safety Expert Panel was charged with the duty of examining the definitions for statin-associated muscle ...
An assessment by the Statin. Cognitive Safety Task Force: 2014 update. Journal of Clinical Lipidology. 2014;8(3,. Supplement):S5-S16. 27. Petersen RC, Lopez O ...
Statin Use for the Primary Prevention of Cardiovascular Disease in ...
USPSTF Assessment of Magnitude of Net Benefit. The US Preventive Services Task Force (USPSTF) concludes with moderate certainty that statin ...
An assessment by the Statin Muscle Safety Task Force: 2014 update
... However, side effects like myalgia, rhabdomyolysis, hepatobiliary problems, myositis, cognitive impairment, and early diabetes may occur. [7, 8, 9,10] Long- ...